Daily, Once-Weekly, or No Asthma Controller Therapy At All: The Annoying Issue with Disease Remission in Clinical Asthma Trials

Am J Respir Crit Care Med. 2021 Feb 1;203(3):273-275. doi: 10.1164/rccm.202008-3161ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Asthma* / drug therapy
  • Double-Blind Method
  • Humans
  • Oligonucleotides
  • Toll-Like Receptor 9*

Substances

  • AZD1419
  • Oligonucleotides
  • TLR9 protein, human
  • Toll-Like Receptor 9